OTCMKTS:ASNB EKIMAS (ASNB) Stock Price, News & Analysis → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free ASNB Stock Alerts $0.61 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.61▼$0.6150-Day Range$0.45▼$0.6152-Week Range$0.55▼$1.75VolumeN/AAverage Volume3,162 shsMarket Capitalization$3.54 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get EKIMAS alerts: Email Address Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. About EKIMASEKIMAS Corp. engages in the development of polymer materials, which provide characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Las Vegas, NV.Read More ASNB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ASNB Stock News HeadlinesMarch 8, 2023 | finance.yahoo.comEKIMAS CORPORATION COMPLETES THE EXERCISE OF WARRANTSMarch 1, 2023 | finance.yahoo.comNORDICUS PARTNERS A/S COMPLETES REVERSE ACQUISITION TRANSACTION WITH EKIMAS CORPORTIONApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. September 14, 2022 | reuters.comASNB.PK - Ekimas Corp | Stock Price & Latest News | ReutersSeptember 12, 2022 | finance.yahoo.comUpdated EKIMAS Corporation Announces Special Cash DistributionSeptember 10, 2022 | yahoo.comWhat does ‘WYLL’ mean on TikTok and Snapchat?August 28, 2022 | finance.yahoo.comEKIMAS Corporation (ASNB)See More Headlines Receive ASNB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EKIMAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/16/2014Today4/26/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:ASNB Previous SymbolAMEX:ASB CUSIPN/A CIK1011060 Webwww.advbiomaterials.com Phone(424) 256-8560Fax978-657-0074Employees11Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-290,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-7,902.31% Return on Assets-5,274.01% Debt Debt-to-Equity RatioN/A Current Ratio0.12 Quick Ratio0.12 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.03 per share Price / Book20.33Miscellaneous Outstanding Shares5,799,000Free Float5,347,000Market Cap$3.54 million OptionableNot Optionable Beta0.37 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesHenrik RoufChief Executive OfficerBennett J. YankowitzChief Financial Officer & DirectorKey CompetitorsMinerva SurgicalNASDAQ:UTRSINVO BioscienceNASDAQ:INVOG Medical InnovationsNASDAQ:GMVDFUnited American HealthcareOTCMKTS:UAHCAethlon MedicalNASDAQ:AEMDView All Competitors ASNB Stock Analysis - Frequently Asked Questions How have ASNB shares performed in 2024? EKIMAS's stock was trading at $0.62 on January 1st, 2024. Since then, ASNB stock has decreased by 1.6% and is now trading at $0.61. View the best growth stocks for 2024 here. How were EKIMAS's earnings last quarter? EKIMAS Co. (OTCMKTS:ASNB) issued its quarterly earnings data on Thursday, October, 16th. The company reported $0.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.29 by $0.02. During the same period last year, the business posted $0.27 EPS. What other stocks do shareholders of EKIMAS own? Based on aggregate information from My MarketBeat watchlists, some companies that other EKIMAS investors own include NVIDIA (NVDA), Associated Banc (ASB), PermRock Royalty Trust (PRT), CytoDyn (CYDY), FuelCell Energy (FCEL), Interpace Biosciences (IDXG), Sphere 3D (ANY), AVEO Pharmaceuticals (AVEO), Boeing (BA) and Bank of America (BAC). How do I buy shares of EKIMAS? Shares of ASNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ASNB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EKIMAS Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.